Formic Acid

Formic Acid

SCHEMBL4911292

O=CO.c1ccc2c(SCc3ccsc3C3=NCCCN3)cccc2c1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.36
NLRP3 Q96P20 1/20 0.36
KMT2A Q03164 1/20 0.36
NISCH Q9Y2I1 5/20 0.36
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
FFAR1 O14842 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 2/20 0.34
TAAR1 Q96RJ0 2/20 0.34
LMNA P02545 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4362117 0.94 SMN1; SMN2 (0.40) SMN1; SMN2NLRP3KMT2ANISCHNPC1
Formic Acid SCHEMBL4911283 0.83 NISCH (0.43) SMN1; SMN2KMT2ANISCHMAPT
SCHEMBL4158125 0.78 NISCH (0.53) SMN1; SMN2NLRP3KMT2ANISCHMAPK1
SCHEMBL4362412 0.78 NISCH (0.45) SMN1; SMN2NLRP3KMT2ANISCHNPC1
Hydrochloric Acid SCHEMBL4907535 0.77 NISCH (0.44) SMN1; SMN2NLRP3KMT2ANISCHNPC1
SCHEMBL4360959 0.76 NISCH (0.47) SMN1; SMN2KMT2ANISCHNPC1RAB9A
SCHEMBL4152820 0.76 NISCH (0.45) SMN1; SMN2NLRP3KMT2ANISCHNPC1
Hydrochloric Acid SCHEMBL4910391 0.75 NISCH (0.44) SMN1; SMN2NLRP3KMT2ANISCHNPC1
Formic Acid SCHEMBL4911286 0.74 NISCH (0.37) NISCHADRA2AADRA2BADRA2CGAA
Formic Acid SCHEMBL4912608 0.74 NISCH (0.51) NISCHMAPK1TAAR1LMNAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof ORE PHARMACEUTICALS, INC. (US) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof MC4R, MC5R, MC3R SMN1; SMN2 3087/4885NLRP3 3694/4885KMT2A 1838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.